Skip to content
The Nexus
DossierENTITY

ranitidine

Coverage of ranitidine in the Nexus archive.

Earliest in view: Jul 21 · 16:24 UTCMost recent: Jul 22 · 12:20 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 22 · 12:20 UTCQUARTZ
    FDA recalled generic allergy tablets that may have been mixed with a heartburn drug

    The FDA has recalled four lots of cetirizine hydrochloride tablets produced by Unique Pharmaceutical Laboratories due to potential contamination with ranitidine. The heartburn drug ranitidine, if present, could cause severe allergic reactions in users.

  • HEALTHJul 21 · 16:24 UTCWSOC ABC CHARLOTTE
    Recall alert: Cetirizine Hydrochloride recalled over cross-contamination

    The FDA has issued a nationwide recall of four lots of Cetirizine Hydrochloride Tablets USP 5 mg produced by Unique Pharmaceuticals due to potential cross-contamination with ranitidine. The affected lots, identified by NDC 16571-401-10 and expiration dates 10/2028, may cause severe allergic reactions in individuals sensitive to ranitidine. No adverse effects have been reported, and consumers are advised to contact Rising Pharma Holdings for further information.

ranitidine · Dossier · The Nexus